Research ExplorerPublicationsAutologous stem cell transplantation in multiple myeloma pat...

Autologous stem cell transplantation in multiple myeloma patients: utilization patterns and hospital effects

Standard

Autologous stem cell transplantation in multiple myeloma patients: utilization patterns and hospital effects. / Jansen, Lina; Merz, Maximilian; Engelhardt, Monika; Weisel, Katja; Scheid, Christof; Straka, Christian; Langer, Christian; Salwender, Hans; Einsele, Hermann; Kröger, Nikolaus; Beelen, Dietrich W; Dreger, Peter; Goldschmidt, Hartmut; Brenner, Hermann; German National Registry for Stem Cell Transplants (DRST).

In: LEUKEMIA LYMPHOMA, Vol. 61, No. 10, 10.2020, p. 2365-2374.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Jansen, L, Merz, M, Engelhardt, M, Weisel, K, Scheid, C, Straka, C, Langer, C, Salwender, H, Einsele, H, Kröger, N, Beelen, DW, Dreger, P, Goldschmidt, H, Brenner, H & German National Registry for Stem Cell Transplants (DRST) 2020, 'Autologous stem cell transplantation in multiple myeloma patients: utilization patterns and hospital effects', LEUKEMIA LYMPHOMA, vol. 61, no. 10, pp. 2365-2374. https://doi.org/10.1080/10428194.2020.1768383

APA

Jansen, L., Merz, M., Engelhardt, M., Weisel, K., Scheid, C., Straka, C., Langer, C., Salwender, H., Einsele, H., Kröger, N., Beelen, D. W., Dreger, P., Goldschmidt, H., Brenner, H., & German National Registry for Stem Cell Transplants (DRST) (2020). Autologous stem cell transplantation in multiple myeloma patients: utilization patterns and hospital effects. LEUKEMIA LYMPHOMA, 61(10), 2365-2374. https://doi.org/10.1080/10428194.2020.1768383

Vancouver

Jansen L, Merz M, Engelhardt M, Weisel K, Scheid C, Straka C et al. Autologous stem cell transplantation in multiple myeloma patients: utilization patterns and hospital effects. LEUKEMIA LYMPHOMA. 2020 Oct;61(10):2365-2374. https://doi.org/10.1080/10428194.2020.1768383

Bibtex

@article{f159c2f5e7ef4ce9bfc03ff9e3986dd9,
title = "Autologous stem cell transplantation in multiple myeloma patients: utilization patterns and hospital effects",
abstract = "Evidence on volume outcome associations for autologous stem cell transplantation (ASCT) in multiple myeloma (MM) is limited. We investigated ASCT utilization patterns and volume outcome associations in the German National Registry for Stem Cell Transplants (DRST). MM patients with an upfront ASCT between 1998 and 2014 registered in the DRST were included. ASCT utilization increased strongly from 6% to 17% between 1999 and 2013 with the largest increase for patients aged 60-64 years (8-34%). The mean number of ASCTs conducted in the hospitals per year varied (quintiles, Q1:0.0-8.2 to Q5:31.0-102.7). Center volume was not associated with survival after upfront ASCT (lowest vs. highest center volume, hazard ratios and 95% confidence intervals: 0.95 (0.76-1.18), p = 0.92). Our findings may reflect a high standard of care and degree of specialization of centers performing ASCT for MM in Germany.",
author = "Lina Jansen and Maximilian Merz and Monika Engelhardt and Katja Weisel and Christof Scheid and Christian Straka and Christian Langer and Hans Salwender and Hermann Einsele and Nikolaus Kr{\"o}ger and Beelen, {Dietrich W} and Peter Dreger and Hartmut Goldschmidt and Hermann Brenner and {German National Registry for Stem Cell Transplants (DRST)}",
year = "2020",
month = oct,
doi = "10.1080/10428194.2020.1768383",
language = "English",
volume = "61",
pages = "2365--2374",
journal = "LEUKEMIA LYMPHOMA",
issn = "1042-8194",
publisher = "informa healthcare",
number = "10",

}

RIS

TY - JOUR

T1 - Autologous stem cell transplantation in multiple myeloma patients: utilization patterns and hospital effects

AU - Jansen, Lina

AU - Merz, Maximilian

AU - Engelhardt, Monika

AU - Weisel, Katja

AU - Scheid, Christof

AU - Straka, Christian

AU - Langer, Christian

AU - Salwender, Hans

AU - Einsele, Hermann

AU - Kröger, Nikolaus

AU - Beelen, Dietrich W

AU - Dreger, Peter

AU - Goldschmidt, Hartmut

AU - Brenner, Hermann

AU - German National Registry for Stem Cell Transplants (DRST)

PY - 2020/10

Y1 - 2020/10

N2 - Evidence on volume outcome associations for autologous stem cell transplantation (ASCT) in multiple myeloma (MM) is limited. We investigated ASCT utilization patterns and volume outcome associations in the German National Registry for Stem Cell Transplants (DRST). MM patients with an upfront ASCT between 1998 and 2014 registered in the DRST were included. ASCT utilization increased strongly from 6% to 17% between 1999 and 2013 with the largest increase for patients aged 60-64 years (8-34%). The mean number of ASCTs conducted in the hospitals per year varied (quintiles, Q1:0.0-8.2 to Q5:31.0-102.7). Center volume was not associated with survival after upfront ASCT (lowest vs. highest center volume, hazard ratios and 95% confidence intervals: 0.95 (0.76-1.18), p = 0.92). Our findings may reflect a high standard of care and degree of specialization of centers performing ASCT for MM in Germany.

AB - Evidence on volume outcome associations for autologous stem cell transplantation (ASCT) in multiple myeloma (MM) is limited. We investigated ASCT utilization patterns and volume outcome associations in the German National Registry for Stem Cell Transplants (DRST). MM patients with an upfront ASCT between 1998 and 2014 registered in the DRST were included. ASCT utilization increased strongly from 6% to 17% between 1999 and 2013 with the largest increase for patients aged 60-64 years (8-34%). The mean number of ASCTs conducted in the hospitals per year varied (quintiles, Q1:0.0-8.2 to Q5:31.0-102.7). Center volume was not associated with survival after upfront ASCT (lowest vs. highest center volume, hazard ratios and 95% confidence intervals: 0.95 (0.76-1.18), p = 0.92). Our findings may reflect a high standard of care and degree of specialization of centers performing ASCT for MM in Germany.

U2 - 10.1080/10428194.2020.1768383

DO - 10.1080/10428194.2020.1768383

M3 - SCORING: Journal article

C2 - 32476543

VL - 61

SP - 2365

EP - 2374

JO - LEUKEMIA LYMPHOMA

JF - LEUKEMIA LYMPHOMA

SN - 1042-8194

IS - 10

ER -